NASDAQ · KRYS
Krystal Biotech, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for KRYS: Nov 02, 2026
Krystal Biotech, Inc. Common Stock is expected to report earnings on 11/02/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $1.84. The reported EPS for the same quarter last year was $2.66.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $1.84 | $1.97 | $1.74 | 4 |
| Dec 2026 | $1.91 | $2.09 | $1.74 | 3 |
| Mar 2027 | $2.48 | $2.48 | $2.48 | 1 |
| Jun 2027 | $2.14 | $2.14 | $2.14 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews · BNK Invest · The Motley Fool- Zacks · Oct 27, 9:00 AM EDTAmgen (AMGN) Reports Next Week: Wall Street Expects Earnings GrowthAmgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 26, 9:00 AM EDTAnalysts Estimate Krystal Biotech, Inc. (KRYS) to Report a Decline in Earnings: What to Look Out forKrystal Biotech (KRYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- RTTNews · Oct 16, 10:55 AM EDTWeekly Buzz: RHHBY, TEVA Win FDA Nod; MLAB, GSK Cut Jobs; AZN, VIR Deals; KRYS, ABBV Report Data(RTTNews) – This week's healthcare roundup brings a series of regulatory wins, corporate restructuring, billion-dollar deals and clinical milestones.
- Zacks · Oct 16, 10:19 AM EDTKRYS Reports Positive Early Data for KB113 in Gorlin SyndromeKrystal Biotech reports promising early results for KB113, with tumor regression seen in more than 80% of assessed lesions in an early Gorlin syndrome study.
- RTTNews · Oct 15, 9:46 AM EDTKrystal Biotech Sees Broad Antitumor Activity With KB113 In Gorlin Syndrome; Stock Up(RTTNews) – Krystal Biotech, Inc. (KRYS) announced positive preliminary clinical data for KB113, an investigational immunotherapy designed to treat basal cell carcinomas (BCCs) in patients with Gorlin syndrome. Krystal shares rose 2.97%.
- RTTNews · Oct 15, 8:59 AM EDTKrystal Biotech Reports Over 80% Lesion Regression With KB113 In Gorlin Syndrome(RTTNews) – Thursday, Krystal Biotech, Inc. (KRYS) announced positive preliminary clinical data for KB113, an investigational intratumoral immunotherapy being developed to treat basal cell carcinomas (BCCs) in patients with Gorlin syndrome.
- BNK Invest · Sep 4, 10:51 AM EDTNotable ETF Outflow Detected – IWO, FROG, BTSG, KRYSLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 2000 Growth ETF (Symbol: IWO) where we have detected an approximate $188.6 million dollar outflow — that's a 1.3% decrease week ove
- Zacks · Sep 3, 11:49 AM EDTKrystal Stock Gains 13.4% in a Month: What Is Driving the Rally?KRYS' Vyjuvek growth and expanding genetic medicine pipeline boost investor confidence as the company advances toward multi-product growth.
- Zacks · Sep 3, 11:30 AM EDTWhy Is Amgen (AMGN) Up 8.6% Since Last Earnings Report?Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks · Sep 2, 11:30 AM EDTKrystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue?Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- BNK Invest · Aug 21, 3:54 PM EDTNoteworthy Friday Option Activity: PZZA, CRK, KRYSAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Papa John's International, Inc. (Symbol: PZZA), where a total of 25,286 contracts have traded so far, representing approximately 2.5 million underlying shares. That amou
- The Motley Fool · Aug 14, 4:20 PM EDTVertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even MoreVertex Pharmaceuticals appears likely to continue to dominate its core therapeutic area.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Krystal Biotech, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.